Many health insurers exclude experimental treatments without clearly defining which treatments they would consider experimental. In this Global Health Brief, RGA's Colin Weston discusses the need for clear definitions in policy language. He also explores how drugs, t...

Read More

GPT-4 features stronger safety and privacy guardrails, longer input and output text, and more accurate, detailed, and concise responses for nuanced questions. Although it offers exciting opportunities for insurance and countless other industries, its potential provid...

Read More

New pharmaceuticals to treat sickle cell disease (SCD) are steadily improving the health and wellbeing of many people living with this chronic disorder. It is hoped that revolutionary gene therapies now in clinical trials will be able to cure more SCD patients. The r...

Read More

In a Society of Actuaries article, RGA's Ryan Holt discusses the confusion matrix and how actuaries have leveraged it in the accelerated underwriting (AU) space.&n... Read More

Thanks to ongoing product and distribution expansion, life and health insurers are finding new ways to differentiate their brands. Fueled by innovation in technology, medicine, and financial services, these advances will help shape life and health insurance in the ye...

Read More

Although much of the spotlight is currently on ChatGPT, the generative artificial intelligence (AI) landscape is much broader. In this article, RGA's Neil Parkin provides an overview of potential opportunities emerging from AI for insurers.

Read More

Asset-intensive reinsurance is growing in popularity in the life insurance industry, and it is more important than ever for insurers to seek out trusted partners when selecting an asset-intensive reinsurer.

Read More

Digital health is here to stay and will continue to grow. Enabling virtual access to healthcare can empower policyholders to actively manage and improve their own health and wellness, while equipping insurers to optimize portfolio management and performance.
Read More

The Geneva Association recently published a comprehensive report on the ongoing mental health crisis and the insurance industry’s role and responsibility in promoting mental wellbeing to help address this growing societal challenge.

Read More

Curious about RGA's medical insights?  Contact us to learn m...

Read More

Explore RGActual, our magazine covering innovation, experience, and development for insurance professionals. In this issue, we continue our celebration with 50 years of positive impact. 

Read More

In the past few decades, groundbreaking advances have emerged in early diagnosis, treatment, and management of cystic fibrosis (CF), and those with the condition are now living to age 60 and beyond. Why, then, are life insurance companies not yet offering terms to those... Read More

The advent of ultra-sensitive troponin testing has led to changes in the way the test is applied and has led to the discovery of many “troponin positive” illnesses that are not due to coronary artery disease. Read More

People are talking about ChatGPT, the AI-powered chatbot capable of processing mountains of text data, providing detailed responses to questions, and engaging in conversation like a human. We decided to put ChatGPT to the test and to consider the implications this tool ... Read More

From a disability insurance standpoint and based on numerous articles in the scientific literature and lay press, insurers might have expected a tsunami of long-term COVID disability claims after the expected six-month waiting period. Thus far, however, this has not bee... Read More

The great promise of gene therapy must be weighed against the challenges of high short-term costs. Effective case management and expanded education efforts will be essential to progress.


Read More

Synthetic biotics show significant promise to prevent, diagnose, and treat diseases and improve future mortality and morbidity rates. If these new therapies successfully enter the market in the coming years, they are likely to help transform modern medicine.


... Read More

Reprinted from De Actuaris, this article reviews the latest developments in the longevity risk transfer market in the Netherlands, some re... Read More

Growing evidence indicates that introducing behavioral science principles to life insurance documentation can be a critical piece of the highly complex puzzle of solving the protection gap.
Read More

RGA provides quarterly updates on global product developments, which can be made available upon request. View the 4Q 2022 digital news...

Read More